~~<i id='64BCE22E5A'><strike id='64BCE22E5A'><tt id='64BCE22E5A'><pre id='64BCE22E5A'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：knowledge 2025-09-27 09:07:01 Page View：2658

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： WHO calls for emergency meeting on new China virus, as cases spread
Next article： Apple is now the first public company to be valued at $3 trillion

knowledge

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

JaeC.Hong/APRoughly7.7%ofAmericansdidn’thaveanyhealthinsuranceasofthispastMarch—a“recordlow”uninsure

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Verily hires former Apple Health leader as chief scientific officer

AndrewTrister,anoncologistandveteranofbigtechnologycompaniesandresearch,isVerily'snewchiefscientific

WSS

leisure time

leisure time

focus

knowledge

Verily hires former Apple Health leader as chief scientific officer